Peficitinib, a investigational medication targeting this specific kinase, presents a encouraging step in the management of rheumatoid arthritis . Early clinical studies suggest that it appears to https://peficitinib274044.veronicablog.com/61458377/peficitinib-a-new-treatment-for-ra-joint-disease